JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HEATHCOTE, R. ST. A.
Right arrow Articles by URQUHART, A. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by HEATHCOTE, R. ST. A.
Right arrow Articles by URQUHART, A. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 38, Issue 2, 145-160, 1930
Copyright © 1930 by American Society for Pharmacology and Experimental Therapeutics


THE PHARMACOLOGICAL AND TOXICOLOGICAL ACTIONS OF ACRIFLAVINE

R. ST. A. HEATHCOTE 1 and A. L. URQUHART 1

1 From the Departments of Pharmacology and Pathology, University of Egypt, Cairo

1. Acriflavine depresses the isolated perfused heart of the toad, by direct action on the cardiac muscle.

2. In moderately dilute solution, it is without action on the smooth muscle of the blood vessels of the toad.

3. Acting directly on the smooth muscle of the isolated rabbit gut, acriflavine, in weak solution, stimulates but, in strong, depresses the pendular movements.

4. In weak solution, it has little or no action on the striated muscle of the gastrocnemius of the toad. In strong solution, however, it is strongly irritant, abolishing the response of the fibers to an electric stimulus and causing them to go into contracture.

5. In the intact animal, on intravenous injection, it lowers the systemic blood pressure of the dog, probably by direct action on the heart. There is no clear evidence as to the existence of any action on the blood vessels.

6. Given intravenously, the m.l.d. of acriflavine for both dog and rabbit is about 30 mgm. per kilogram body weight.

7. Dogs, injected intravenously at short intervals of time with acriflavine in doses of from 5 to 25 mgm. per kilogram, develop pathological changes in the liver and kidney and display evidence of extensive destruction of the erythrocytes and of derangement of the general metabolism.

Submitted on July 18, 1929







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1930 by the American Society for Pharmacology and Experimental Therapeutics.